IP Verse

Moderna Therapeutics competitive analysis

Loading summary...

Latest oppositions filed by Moderna Therapeutics

Explore patent oppositions filed by Moderna Therapeutics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3115064
Rna-Coded AntibodyCUREVACAug 24, 2022

Latest patents of Moderna Therapeutics opposed by its competitors

Explore Moderna Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2791160
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions10
EP2922554
Feb 23, 2022Terminally Modified Rna1
EP3019619
Aug 25, 2021Compositions Comprising Synthetic Polynucleotides Encoding Crispr Related Proteins And Synthetic Sgrnas And Methods Of Use2
EP3492109
Mar 4, 2020Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof2

Latest publications and patents of Moderna Therapeutics New

Explore the latest publications and patents granted to Moderna Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 16, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Moderna Therapeutics

EP2791160
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsRevoked
EP2922554
Feb 23, 2022Terminally Modified RnaRevoked
EP3019619
Aug 25, 2021Compositions Comprising Synthetic Polynucleotides Encoding Crispr Related Proteins And Synthetic Sgrnas And Methods Of UseGranted And Under Opposition
EP3492109
Mar 4, 2020Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofRevoked

Latest PTAB cases involving Moderna Therapeutics

Discover the latest PTAB cases involving Moderna Therapeutics, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 22, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Moderna Therapeutics

IPR2019-00554Jan 9, 2019MODERNAARBUTUS BIOPHARMAFinal Written Decision
IPR2019-00554Jan 9, 2019MODERNA THERAPEUTICSARBUTUS BIOPHARMAFinal Written Decision
IPR2018-00739Mar 5, 2018MODERNAARBUTUS BIOPHARMAFinal Written Decision
IPR2018-00739Mar 5, 2018MODERNA THERAPEUTICSARBUTUS BIOPHARMAFinal Written Decision
IPR2018-00680Feb 21, 2018MODERNAARBUTUS BIOPHARMAFinal Written Decision
IPR2018-00680Feb 21, 2018MODERNA THERAPEUTICSARBUTUS BIOPHARMAFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Moderna Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MODERNA57542
ARBUTUS BIOPHARMA - 6 - 3
BIONTECH3061 -
MAIWALD135 - - -